We are live on ! Find out more
CELGZ

Celgene Corporation Contingent Value Rights

Delisted

CELGZ was delisted on the 29th of November, 2019.

21 hedge funds and large institutions have $343K invested in Celgene Corporation Contingent Value Rights in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

5% more funds holding

Funds holding: 2021 (+1)

69% less capital invested

Capital invested by funds: $1.1M → $343K (-$754K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 6

Holders
21
Holders Change
+1
Holders Change %
+5%
% of All Funds
0.47%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
6
Closed
1
Calls
Puts
Net Calls
Net Calls Change

CELGZ Hedge Fund Activity: Q4 2018 in Review

21 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q4 2018, worth a combined $343K — down 69% from $1.1M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CELGZ positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 6 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $101K. The largest seller was FCG Advisors, cutting an estimated $36K.

  • 21 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q4 2018, up from 20 in Q3 2018.
  • Funds reported $343K of Celgene Corporation Contingent Value Rights stock for Q4 2018, down 69% quarter-over-quarter.
  • 2 funds opened new Celgene Corporation Contingent Value Rights positions in Q4 2018 and 1 closed out, a net change of +1 holder.
  • The largest Celgene Corporation Contingent Value Rights buyer in Q4 2018 was Susquehanna International Group, an estimated $101K added.
  • The largest Celgene Corporation Contingent Value Rights seller in Q4 2018 was FCG Advisors, an estimated $36K sold.

Based on aggregated 13F filings for Q4 2018.